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Teratological Research Using In Vitro
Systems. . Mammalian Whole Embryo
Culture
by Thomas J. Flynn*
Approximately 390 literature references (through spring 1986) were reviewed for mammalian whole
embryo culture procedures, with particular attention to the development ofthose cultures as systems for
teratogenicity testing. The existingprocedures could be conveniently divided into three groups, which are
defined by the periods ofembryogenesis that they embrace: preimplantation, peri-implantation, and post-
implantation culture systems. The literature on peri-implantation embryo culture was sparse, and it did
not appear that this procedure is being actively developed as a teratogen screening test. The extensive
literature on both preimplantation and postimplantation embryo culture suggested considerable use of
these two methods in evaluating embryotoxicants.
The following discussion was compiled from information gleaned from all references. However, in the
interest ofbrevity, only representative articles are specifically cited. Because the background and meth-
odology for each system are distinct, each system will be discussed separately.
Preimplantation Embryos
Introduction
The procedures for the culture of preimplantation
mouseembryosfromthetwo-celltotheblastocyst stage
were developed in the late 1950s and early 1960s, pri-
marily through the work of Whitten and Brinster (1).
Kane (2) described conditions for culturing preimplan-
tation rabbit embryos in a defined medium. Some suc-
cess hasbeenachieved inculturingpreimplantation em-
bryos from larger species, including human, but these
species require undefined media that contain serum.
Interest in preimplantation embryo culture as a
screen for environmental teratogenesis arose from ob-
servations that preimplantation embryos, both in vivo
and in vitro, are highly susceptible to the damaging
effects of ionizing radiation. Simple procedures are
available forobtainingmetaphase chromosomal spreads
frompreimplantation embryos, thus makingthem ideal
for studies on agents for which chromosomal damage is
suspected ofbeing the mechanism ofreproductive tox-
icity. A literature search through spring 1986 revealed
53 references in which preimplantation embryos were
used to evaluate the embryotoxicity of48 different en-
vironmentalagents. Preimplantationembryos fromrats
were used in one of these studies, and the remainder
used embryos from mice.
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Methodology
Both general methods ofpreimplantation mouse em-
bryo culture (1) and methods applicable to teratology
studies (3) have been reviewed and described. Female
mice are both time-ovulated and superovulated with
gonadotropins, mated to fertile males, and examined
for vaginal plugs to confirm positive mating. Pregnant
females are killed 36 hr after ovulation, the oviducts
areexcised, andtwo-cellstageembryosareflushedfrom
the oviducts. Because ofthe hormonal superovulation,
20 to40 embryos canbe obtained from eachfemale. The
embryosaretransferredtoachemicallydefinedmedium
and incubated at 3700 in an atmosphere of 5% carbon
dioxide in air. Cultured embryos develop normally for
72 hruptotheblastocyststage. Atthis point, theymay
beexamineddirectly, transferredtooutgrowthmedium
for an additional 120 hr, and then examined for devel-
opment ofembryonic germinal tissue, or transferred to
pseudopregnant females and examined at various times
throughout gestation for normal embryonic develop-
ment.
Critical Review
Forty-eight different agents (including chemicals,
physical agents such as X-irradiation, and biological
agents such as viruses and antibodies) have been used
on cultured preimplantation embryos to evaluate em-
bryotoxicity. The basic culture procedures appeared to
beuniform amongdifferentlaboratories, withthemajor
variations being the choice of medium and strain ofT. J. FLYNN
mouse. Specific aspects of a system that relate to its
use as a teratology screen (e.g., end points, presence
ofmetabolic activation) are much more variable.
End Points. The major end points used are the
survival of embryos and the visual appearance of sur-
viving embryos. Survival provides only a quantal re-
sponse (i.e., dead oralive). Questions can also be raised
as to whether a dead embryo represents a true embry-
otoxicity or merely a generalized cytotoxic response.
The appearance ofsurviving embryos is used to eval-
uate the ability of the test agent to inhibit normal
growth and morphogenesis ofthe preimplantation em-
bryos. However, it is not usually determined whether
a test embryo at an earlier developmental stage than
control embryos has experienced developmental retar-
dation or has died at the early stage and not yet no-
ticeablydegenerated. Anotherproblemarises when au-
thors report no effect of an agent based on the ability
of treated embryos to achieve a "normal" morphology
forthedevelopmental stage atwhichtheyare examined
(e.g., morula, blastocyst, etc.). It has been demon-
strated (3) thatembryos that have anormal appearance
at the gross level may not be normal when examined
by other means. The major mechanism for this mis-
judgment appears to be selective cell death, whereby
enough cells remain to give the embryo an overtly nor-
mal appearance. Many authors supplement the gross
examination with a determination ofthe actual number
of cells in the treated and control embryos. Although
thisprocedurewillidentifyembryoswith asignificantly
reduced cell number, it will not identify embryos in
which a small number of cells killed by the test agent
is critical to the further development ofthe embryo.
This latter point has been evaluated by examining
further development of treated embryos in two ways.
First, embryos cultured up to the blastocyst stage can
be transferred to outgrowth medium (4). This medium
allows blastocysts to undergo a further pseudodevel-
opment. Normal outgrowths will form two distinct an-
lage consisting of trophoblast cells, which are repre-
sentative of extraembryonic structures, and an inner
cellmass (ICM), whichgives risetotheembryoproper.
The ICM will further differentiate into embryonic ec-
toderm and endoderm. Agents have been described (5)
that apparently selectively destroy the relatively few
cells in the blastocyst that give rise to the ICM. Thus,
apparently normal blastocysts yield outgrowths com-
posed entirely oftrophoblast cells.
The second means used to evaluate postimplantation
developmental potential after in vitro preimplantation
exposure to agents is embryo transfer (6). In this pro-
cedure, cultured blastocysts are transferred to the
uterus ofpseudopregnant females. The females can be
killed and the embryos examined for abnormal devel-
opment at any time during gestation. One limitation of
this procedure is the relatively low (about 50%) success
rate ofdevelopment ofall transferred embryos, includ-
ing untreated controls.
Some end points provide more quantitative datathan
gross morphological appearance. Cytological parame-
ters, such as the number of micronuclei, the nuclear
labeling index (7), and the rate of sister chromatid ex-
change, (8) have been determined in control versus
treated cultured embryos. Biochemical indexes, such as
rate ofincorporation of 'S-methionine into protein (9)
andincorporationof3H-uridineintoRNA(10), havealso
been used. These quantitative end points also provide
information about possible mechanisms ofaction ofem-
bryotoxic agents. The cytological parameters reveal
agents that act through genetic mechanisms such as
mutation; the biochemical parameters reveal agents
that actthrough disruption ofnormal cellular processes
such as RNA or protein synthesis.
Dose Response. In most of the studies in which
chemicalagentswereusedasatoxicinsult, theembryos
were placed directly into medium containing the chem-
ical, and the embryo was exposed to the chemical
throughout the culture period (24-72 hr). Only three
studies were found in which embryos were exposed for
short periods oftime and then transferred to fresh me-
dium (11-13). Exposure to physical insults such as ul-
traviolet or X-irradiation was always on a short-tern
basis (14). In general, when multiple levels of a test
agent were used, a dose-response was obtained for at
least one ofthe end points examined by the authors. In
manycases, the authors provided agraphical depiction,
but no formal statistical analysis of the dose-response
(e.g., regression analysis, analysis ofvariance, etc.). It
wasalsoapparentthatmostoftheagentsandendpoints
used produced very steep dose-response curves. The
concentrations causing 0% and 100% effects often lay
within an order ofmagnitude of each other.
The lowest concentrations of chemical agents re-
ported by most authors as producing a significant re-
sponse were in the micromolar range. The most potent
agent studied with the preimplantation embryo system
was Shigella toxin, which inhibited protein synthesis
and further development of embryos at concentrations
in the medium as low as 0.1 pg/mL (15). The leasttoxic
agent tested was phenol, which yielded observable ef-
fects only at concentrations in the medium above 5 mM
(470 ,ug/mL). Several agents were reported that had no
observable effects on in vitro embryonic development
at the highest concentrations used.
Types ofCompounds That Can Be Studied. The
48 agents that have been used in the preimplantation
embryo culture system to evaluate embryotoxicity are
representative of a number of classes. These include,
but are notlimited to, variousformsofradiation, heavy
metals, chemotherapeutic agents, nonsteroidal anti-in-
flammatory drugs, viruses, plant and microbial toxins,
and specific enzyme and metabolic inhibitors. The vast
majority of chemical agents used were water-soluble
compounds that were readily soluble in the culture me-
dium. Addition ofhuman serum to the culture medium
can also be used to identify some embryotoxic serum
factors (16).
The standard protocol for preimplantation embryo
culture calls for injecting drops of medium under par-
affinoilinculturedishes. Theoverlaidparaffinoilallows
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gas diffusion, but retards evaporation of the medium.
This paraffin oil extracts lipophilic compounds from the
medium (17). Thus, the study of lipophilic agents re-
quirestheuseofnonstandardcultureprocedures. Meth-
ods used to incorporate poorly soluble compounds into
the medium included direct weighing of prostaglandin
PGF21 into the medium during preparation (18); and
dissolution of phorbol esters (19) and benzo[a]pyrene
(11) in dimethylsulfoxide (DMS0), followed by addition
ofDMSO to the medium at final DMSO concentrations
ofup to 0.1%.
Metabolic Activation. Preimplantation embryos
fromsomestrainsofmicehavebeenreportedtopossess
inducible metabolic activity toward polycycic aromatic
hydrocarbons (20). They have not yet been shown to
possess any other xenobiotic-metabolizing capabilities.
Pedersenetal. (11)introducedmore substantialinvitro
metabolic capabilities byincubating embryos for30 min
inmediumcontainingbenzo[a]pyrene and a standard S-
9 preparation with cofactors, and then returning the
embryos to conventional culturemediumforfurtherde-
velopment. Burki and Sheridan (21) used in vivo met-
abolic activation by injecting the alkylating agent TEM
into male mice before mating. Embryos fertilized by
these males were then cultured and examined for chro-
mosomal anomalies.
Time, Personnel, and Cost Requirements. Since
there is no single standardized protocol for develop-
mental toxicity testing with preimplantation embryos,
time, personnel, and cost requirements vary according
tothe finalprocedures selected. Forexample, the num-
ber ofembryos obtained per mouse varies from 6 to 12
to 30 to 40, depending on whether or not gonadotropins
were used to induce superovulation. If gonadotropins
were used, the increased number ofembryos involved
will necessitate either an increase in personnel or a de-
crease innumberofanimals used perexperimental run.
Thechoice amongtheseoptions willalsoinfluencecosts,
sincepersonnel costswouldnonnallybehigherthanthe
costs of purchasing mice. However, the savings
achieved by reducing personnel may be offset by an
increase in the number ofexperimental runs needed to
obtain enough embryos for statistical analysis, with a
subsequent increase in total time required.
The choice ofan end point will also greatly influence
total time, personnel, and cost requirements. A stan-
dard preimplantation culture from initiation of timed
ovulationthrough removal oftwo-cell stage embryos to
theblastocyststagetakesatotalof8days. Anadditional
5days(oratotalof13days) areneedediftheblastocysts
are left to develop as explants; an additional 14 to 15
days (or a total of22-23 days) are required ifthe blas-
tocysts are transferred to pseudopregnant females and
allowed to develop to tern. End points otherthan mor-
phological development, e.g., biochemical or cytoge-
netic assays, will extend these times depending on the
complexityoftheassayandthetotalnumberofembryos
to be assayed. The number of embryos used varies
greatly from study to study, but a minimum of about
25 per treatment group with an average of about 100
per group seems most common.
A great deal oftechnical skill is required for all pro-
ceduresinpreimplantationmammalianembryology. Be-
cause of the small size of embryos at this stage, all
manipulations must be done under a microscope. Stan-
dardcultureprocedures, suchassterility, mustbemain-
tained throughout. If embryo transfer techniques are
used, considerable skill in surgeryonmice isnecessary.
Nonpersonnel costs of preimplantation embryo cul-
ture are relatively modest (T. Flynn, personal obser-
vation). Major equipment required includes dissecting
microscopes, a carbon dioxide incubator, and an auto-
clave. Although embryo culture medium is available
commercially, it can be prepared easily from inexpen-
sive components.
Utility in Mechanistic Studies. Because of their
rapid rate ofcell division and the ease with which met-
aphase spreads can be prepared, preimplantation em-
bryos are useful for uncovering genotoxic mechanisms
of developmental toxicants. Preimplantation proce-
dures canbe extended totreatmentperiodsbeforemat-
ing to evaluate reproductive hazards stemming from
genotoxic effects on eithermale orfemalegametes (22).
However, because of the limited period of gestation
represented by these embryos and the limited amount
of differentiation they undergo, preimplantation em-
bryos are probably not of much value in elucidating
nongenetic mechanisms of embryotoxicity.
Utility as a Screen for Teratogens. There do not
appear to have been any serious efforts made toward
standardizingorvalidatingpreimplantationembryocul-
ture as a teratogen screening assay.
Per-implantation Embryos
Introduction
A number ofprocedures are available for the culture
ofmammalian embryos at the peri-implantation stage.
Wiley and Pedersen (23) successfully cultured mouse
blastocysts to the egg cylinder stage. Rizzino and Sher-
man(24)laterdescribedaserum-freemediumformouse
blastocyst culture. Tam and Snow (25) were able to get
60%ofearlyprimitive-streakmouseembryostodevelop
for 48 hr in culture. Chen and Hsu (26) cultured mouse
embryos from the blastocyst to the limb bud stage, but
the cultureprocedureusedwascomplexandthesuccess
rate was low.
Procedures have also been described for the culture
of peri-implantation rabbit (27) and rat (28) embryos.
However, the literature on these species is not as ex-
tensive as that for the mouse.
Methodology
Apparentlythere is no standard methodology forcul-
ture of peri-implantation embryos. Both static and ro-
tating culture systems have been used. Culture media
have been described that are either serum-free or con-
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tain one or more ofthe following sera: fetal calfserum,
newborn calfserum, human cord serum, mouse serum,
or rat serum. Embryos are cultured either in the same
medium throughout or transferred to different media
as culture progresses. More detailed descriptions ofthe
individual procedures can be found in references (23-
28).
Critical Review
Peri-implantation embryo culture does not appear to
have been seriously considered as a procedure for eval-
uating embryotoxicity. In the literature search, only
eight studies werefound in whichperi-implantation em-
bryoswereexposedtotoxicagents. Ofthese eightstud-
ies, only three indicated that evaluation ofmechanisms
ofteratogenicity was theprimarygoal ofthe study (29-
31). Lack ofstandardized procedures and poor survival
rate have probably kept peri-implantation embryo cul-
ture from being used more for screening teratogens.
Postimplantation Embryos
Introduction
Although methods for culturing postimplantation
mammalian embryos were first described in the 1930s,
New and his coworkers (32) are generally credited with
establishing the contemporary methodology for organ-
ogenesis-stage mammalian embryo culture during the
1960s and 1970s.
Use of postimplantation embryo cultures as a tera-
tology screen developed slowly because initial culture
procedures resulted in a poor overall rate ofsurvival of
the embryos and significant differences between sur-
vivingcultured embryos andtheircounterparts invivo.
New et al. (33) reported on culture conditions that al-
lowed more than 95% of rat embryos explanted from
the uterus ongestation day9(headfold stage)to survive
in culture for 48 hr. These same authors (34) also dem-
onstrated that their embryonic development in vitro
wasindistinguishable fromthatofpairedlittermatecon-
trols left to develop in utero. Wee et al. (35), using
New's technique, sustained day 14.75 mouse embryos
in culture for limited periods to study palatal shelf ro-
tation. Sadler(36) modified New's culture conditionsfor
rat embryos and successfully cultured mouse embryos
for48hrstartingongestationday8(earlysomitestage).
Tarlatzis et al. (37) described amodified apparatus that
allows continuous culture ofrat embryos for 96 hr. At-
tempts have been made to culture organogenesis-stage
embryos from other species, but thus far none ofthese
species has matched the mouse or rat in either ease of
culture or consistency ofresults.
The period ofsuccessful culture, embryonic days 9 to
11 in the rat and days 8 to 10 in the mouse, corresponds
to the period ofmajor organogenesis in these rodents.
This same period is the one which, as whole animal
teratology studies indicate, is most sensitive to tera-
tological insult. Since the mid-1970s, several research
groups have used whole embryo culture as a means of
evaluatingorelucidatingmechanismsofactionofknown
or suspect embryotoxic agents. A search of literature
datingthroughspring1986revealedmorethan200stud-
ies in which postimplantation embryo culture was used
to evaluate teratogens.
Methodology
The basic culture procedures derive from those de-
scribed by New et al. (33,34). Rat embryos are ex-
planted fromthe uterus atthe headfold stage (gestation
day 9.5), with the yolk sac and ectoplacental cone left
intact. Embryos are transferred to 30 mL culture bot-
tles, oneortwoembryosperbottle. Theculturemedium
is 4 mL of whole rat serum, which must be prepared
by centrifuging freshly drawn rat blood before it clots.
The serum must also be heat-inactivated at 5600 for 30
min. The culture bottles are then equilibrated with a
gas mixture of5% oxygen, 5% carbon dioxide, and 90%
nitrogen, sealed tightly, and rotated in a horizontal po-
sition at 40 to 50 rpm. The culture bottles are re-equi-
librated at 24 and 32 hr with gas mixtures containing,
respectively, 20% and40% oxygen, with carbon dioxide
remaining constant at 5% and nitrogen providing the
balance.
Critical Review
A major drawback to whole embryo culture as a ter-
atology screen is the lack ofuniformity in experimental
conditions between laboratories. These differences in-
clude variations in actual culture procedures, quanti-
tation of end points, inclusion of metabolic-activating
capability, and choice ofspecies or strain.
EndPoints. Mostauthorsusesomecriteriaforeval-
uating the viability ofthe cultured embryos, with non-
viable embryos being eliminated from the final data
analysis. The factors used for evaluating viability in-
clude lack ofobvious physical trauma (e.g., tears in the
yolk sac), a regularly beating heart, and presence ofan
active yolk sac blood circulation.
The most common criterion used as an end point is
the overall morphology of treated versus control em-
bryos. Embryos are observed under a dissecting mi-
croscope for delayed or abnormal development overall
or in specific organ systems. Various measurements
such as crown-rump and head lengths can be obtained
with an eyepiece reticle, and the number ofdorsal som-
ite pairs can be counted. Brown and Fabro (38) have
described a detailed anatomical scoring system which
provides a quaqntitative assessment ofoverall anatom-
ical development ofsomite-stage rat embryos.
Biochemical end points have been used frequently to
assess viability. The most common end points are the
total DNA and protein contents ofthe embryos. Other
biochemical parameters that have been measured in-
clude total RNAcontent; totalhemoglobincontent; em-
bryonicandyolksacDNA, RNA, andproteinsynthesis;
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yolk sac ornithine decarboxylase activity; glycosami-
noglycan staining; and lactic acid release.
Allen et al. (39) described a cytogenetic end point
wherebythe numberofsisterchromatid exchanges was
determined inembryosexposed eitherinvivoorinvitro
to cyclophosphamide or its metabolites.
Dose Response. Most studies used multiple doses
oftest agents, and in all cases in which apositive effect
of the agent was observed, the effect was reported to
be dose-related.
Most agents appeared to affect cultured embryos in
the millimolar concentration range. Actinomycin D (40)
was apparently the most potent substance tested; it
produced significant effects in cultured embryos at a
concentration in the medium of0.3 ng/mL. Ethanol (41)
seemed to be the least active compound tested, since
significant effects were observed only at medium con-
centrations above 2 mg/mL. L-Glucose was ineffective
at concentrations as high as 15 mg/mL (42). Thus, the
whole embryo culture system can respond to agents in
the medium over a concentration range ofabout 108.
Warner et al. (43) have shown thatthe whole embryo
systemcanbe manipulated tomore closelyapproximate
theexpectedinvivoexposure conditions. These authors
determined the peak plasma concentration and half-life
of an in vivo teratogenic dose of hydroxyurea. They
duplicatedthese exposure conditionsforculturedmouse
embryos. The spectrum of abnormalities observed in
vitro closely mimicked those seen in vivo.
Types ofCompounds That CanBe Studied. There
do not appear to be any limitations on the types of
compounds oragentsthatcanbetestedwiththepostim-
plantation embryo culture system. A list compiled from
literature references showed that 181 agents have been
tested onratembryos and26agents onmouseembryos.
Because most ofthe chemicals used werewatersoluble,
they were added to the medium in aqueous solution.
Embryoswereexposedtowater-insoluble compounds
in a number of ways. Tunicamycin was administered
locally to cultured embryos by first coating it onto a
human eyelash and then implanting the eyelash in the
regionofthe embryonicnasalplacode (44). Retinoic acid
(45) and chlorambucil (46) have been added to culture
serum dissolved in ethanol. DMSO has been used as a
solvent for several compounds such as 2-acetylamino-
fluorene (47). Sim et al. (48) were able to disperse jer-
vine in an aqueous suspension by sonication. Satish et
al. (49), using microinjection, directly injected phos-
phoramide mustard into variousregions ofcultured em-
bryos.
Kitchin and Ebron (50) have made a comprehensive
study on solventtoxicity and water-insoluble compound
delivery to cultured embryos. These authors found that
Tween 80, acetone, ethanol, and DMSO were all toxic
atmediumconcentrations greaterthan0.1%. However,
cornoilcould besuspended in serumbyultrasound, and
it was nontoxic at concentrations up to 2.5%.
Metabolic Activation. Somite-stage mouse em-
bryos have been shown to metabolize benzo[a]pyrene
to active metabolites (51) and to possess an inducible
cytochrome P-450 activity for 2-acetylaminofluorene
metabolism (52). Day 10 rat embryos possess a cyto-
chrome P-450 activity that can be induced transplacen-
tally with 3-methylcholanthrene (53), as well as an en-
dogenous activitycapable ofmetabolizingaflatoxin (54).
Severalapproacheshavebeentakentoincorporatemet-
abolic activation capabilities into the postimplantation
embryo culture system.
Fantel et al. (55) first reported on the inclusion ofan
S-9 system, which was comparable to that used in in
vitro mutagenicity assays, into the embryo culture me-
dium. These authors showed that cyclophosphamide, a
toxic compound known to require metabolic activation,
was toxic to cultured embryos only when the S-9 frac-
tion and appropriate cofactors were incorporated into
the culture system. Kitchin et al. (56) modified this ap-
proach slightly by using a purified microsomal fraction
in place ofthe crude S-9 preparation.
Oglesby et al. (57) reported on the successful co-cul-
ture of rat, hamster, and rabbit hepatocytes with rat
embryos. This system provides a means of examining
speciesdifferencesinsensitivitytochemicalteratogens.
In cases where the metabolites ofasuspectteratogen
are known and chemically stable, they can be added
directly to the culture medium. This approach provides
information on the nature of the proximate teratogen.
Mirkes et al. (58) studied the effects of three stable
metabolites ofcyclophosphamide on cultured embryos.
These authors showed that only one metabolite, phos-
phoramide mustard, could duplicate the effects seen
with bioactivated cyclophosphamide. Mirkes and other
research groups have used this approach on other par-
ent compounds and their stable metabolites.
Variousmethodshavebeenusedforobtaininginvivo
bioactivation oftestcompounds, includingdirectinvivo
exposure. Beaudoin and Fisher (59) administered a
number ofenvironmental toxins to pregnantrats either
4 or 24 hr before recovery and culture of day-10 rat
embryos. All compounds tested were shown to inhibit
in vitro development ofthe embryos.
An alternative approach to obtaining in vivo bioac-
tivation is the use of serum from animals treated with
the test compound as the culture medium. Klein et al.
(60) treated adult rats with either cadmium or cyclo-
phosphamide and then obtained serum at various in-
tervals after treatment. The response of cultured em-
bryos to the various sera was dependent on the time
interval between treatment of the animal and with-
drawal ofthe blood. Sadler (61) showed that serum ob-
tained from diabetic rats induced abnormalities in cul-
tured mouse embryos. Two hypolipidemic drugs, which
were known in vivo teratogens, were shown to act di-
rectly on cultured embryos (62), while hypolipidemic
serum from treated animals did not induce anomalies.
This finding suggested that the drugs themselves and
not maternal hypolipemia were the cause ofinvivo ter-
atogenesis.
Klein and his co-workers have extended the in vivo
bioactivation approachbysuccessfullyculturingratem-
bryos on human (63) and monkey (64) serum supple-
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mented with glucose. It was shown in the former study
that serum from humans undergoing treatment with
either chemotherapeutic or anticonvulsant agents was
teratogenic to embryos in vitro.
Time, Personnel, and CostRequirements. Sadler
andWarner (65) have evaluated thetime, material, and
costs for screening one compound using postimplanta-
tion mouse embryo culture. Their analysis was based
onusingfourgroups of21 embryos, or84totalembryos.
The total time needed was estimated at 40 technician-
hours; thus, the overall time required depends on the
number of technicians available. A technician's salary
was estimated at$7.50perhr, andnoconsiderationwas
given to the cost of housing the animals. The final es-
timate (65) was $713.80 for screening one compound.
Norman Klein (1984, personalcommunication) hases-
timated that the cost of postimplantation rat embryo
culture is $30 per culture bottle, of which $20 is labor
cost and the remaining $10 is materials. Since two em-
bryos are cultured per bottle, four treatment groups of
12 embryos per group would require 24 bottles. This
would give a minimum cost of $720 for screening one
compound.
The initial investment for postimplantation embryo
culture is not extraordinary. Majorequipment required
includes an incubator, dissecting microscopes, rotator
apparatus, and either custom gas mixes or a precision
three-waygas mixingvalve. Provisionsforworkingun-
dersterile conditions are helpfulbut notabsolutely nec-
essary. A suitable laboratory for whole embryo culture
could probably be equipped for less than $20,000.
Because all manipulation ofthe embryos from initial
explantation to final evaluation must be done under a
microscope, a high degree of skill is required by all
personnel. Assuming that enough skilled people were
available so that only one experimental run was nec-
essary, 12 days would be required (from mating ofrats
to completion ofculture) to test one agent. This period
would be somewhat longerifany elaborate assays were
performed on the embryos.
Utility in Mechanistic Studies. Because postim-
plantation embryos in culture can be observed contin-
uouslythroughouttheperiodoforganogenesis inawell-
controlled environment, this system has the potential
to provide much useful information about the mecha-
nisms of action of suspect developmental toxicants.
Either parent compounds or known metabolites can
beadded totheculturemedium. Thisapproachprovides
information on the nature of the proximate teratogen.
Embryos canbeevaluatedbiochemicallyforcluestothe
underlying mechanisms of teratogenesis. Huber and
Brown (66) showed that theteratogenic effects ofphor-
bol esters resulted from adisruption ofthemorphology
andfunctionofthevisceralyolksacandnotfromadirect
attackontheembryo. Thispointisimportantinrelating
results ofanimal experiments to human risks, because
human embryos do not have any structure comparable
to the rodent yolk sac placenta.
UtilityasaScreenforTeratogens. Althoughwhole
embryocultureisbeingactivelyendorsedasateratogen
screen by several groups (40,65,67), only one of these
groups (40) seems to have taken the necessary steps
towardvalidation. All 18oftheknownteratogenstested
and 20 of the 21 nonteratogens tested were correctly
classified. However, there was no indication that these
were blind studies.
Whole embryo culture may also be useful fordirectly
screening humans at reproductive risk and predicting
possible palliative measures. Ferrari et al. (68) were
able to identify nutritional deficiencies in women with
poorreproductive histories bytheinability oftheirsera
tosupport development ofratembryosinvitro. Dietary
supplementation with the appropriate nutrients re-
versed, in some cases, both the embryotoxicity of the
serum and the poor reproductive performance of the
woman.
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